United States · FDA National Drug Code directory
Levothyroxine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-456_415fc774-31a5-124f-e063-6294a90a0e46
- Product NDC
- 16729-456
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Accord Healthcare Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201203
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 175 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (16729-456-15) · 16729-456-15
- 1000 TABLET in 1 BOTTLE (16729-456-17) · 16729-456-17
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →